Molten Ventures partner Inga Deakin targets healthcare data, non-invasive devices investment themes

• Molten Ventures Partner Inga Deakin outlined a health and bio investment focus spanning pharmaceuticals, biotech, medical devices, healthcare systems, and consumer health.
• Deakin said she leads investments across the full lifecycle, including thesis work, pricing and leading rounds, contract execution, and board support.
• She said Molten typically leads rounds, with early engagement often more than a year before an investment is finalized.
• Key 2025 themes cited included proprietary healthcare data capture, software to improve clinical workflows, and better integration of hospital data streams.
• Deakin said she sits on five boards tied to deals she has led in recent years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Molten Ventures plc published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.